Consolidation radiotherapy in the treatment of advanced Hodgkin’s disease: is it dead?
- 1 July 2003
- journal article
- Published by Elsevier in International Journal of Radiation Oncology*Biology*Physics
- Vol. 56 (3), 605-608
- https://doi.org/10.1016/s0360-3016(03)00130-5
Abstract
No abstract availableThis publication has 16 references indexed in Scilit:
- Meta-analysis of chemotherapy versus combined modality treatment trials in Hodgkin's disease. International Database on Hodgkin's Disease Overview Study Group.Journal of Clinical Oncology, 1998
- Randomized study of intensive MOPP-ABVD with or without low-dose total-nodal radiation therapy in the treatment of stages IIB, IIIA2, IIIB, and IV Hodgkin's disease in pediatric patients: a Pediatric Oncology Group study.Journal of Clinical Oncology, 1997
- Further chemotherapy versus low-dose involved-field radiotherapy as consolidation of complete remission after six cycles of alternating chemotherapy in patients with advanced Hodgkin's diseaseAnnals of Oncology, 1995
- Low-Dose Involved Field Radiation after Chemotherapy in Advanced Hodgkin Disease: A Southwest Oncology Group Randomized StudyAnnals of Internal Medicine, 1994
- Randomized trial of chemotherapy versus chemotherapy plus radiotherapy for stage III-IV A &B Hodgkin's diseaseAnnals of Oncology, 1992
- Combined modality therapy of Hodgkin's disease: 10-year results of National Cancer Institute of Canada Clinical Trials Group multicenter clinical trial.Journal of Clinical Oncology, 1991
- Improved survival in advanced Hodgkin's disease with the use of combined modality therapyInternational Journal of Radiation Oncology*Biology*Physics, 1990
- Combined modality therapy for advanced Hodgkin's disease: 15-year follow-up data.Journal of Clinical Oncology, 1988
- The evolution and summary results of the Stanford randomized clinical trials of the management of Hodgkin's disease: 1962–1984International Journal of Radiation Oncology*Biology*Physics, 1985
- A randomized study comparing chemotherapy alone with chemotherapy followed by radiotherapy in patients with pathologically staged IIIA Hodgkin's disease.Journal of Clinical Oncology, 1984